Healthcare

Alphatec Holdings, Inc. (ATEC)

Market Cap
P/E Ratio
Beta
Dividend Yield
Piotroski 6/9Beneish M -3.40 Clean

Quantitative Summary

Deterministic

Financial health is average: Piotroski 6/9.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

6/9
Piotroski F-Score
Average — mixed operational signals
-3.40
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

69.6%
Gross Margin
-18.8%
Net Margin
-13.5%
ROIC
+24.9%
Revenue Growth (YoY)
+11.6%
Earnings Growth (YoY)
-4.4M
Free Cash Flow

Balance Sheet Health

62.67x
Debt / Equity
2.06x
Current Ratio
-2.1x
Interest Coverage
-14.9M
EBITDA

Earnings Surprise History

Q4
✓ Beat
Est: $-0.12
Act: $-0.09
+27.2%
Q3
✓ Beat
Est: $-0.04
Act: $0.02
+148.0%
Q2
✓ Beat
Est: $-0.02
Act: $0.03
+233.4%
Q1
✓ Beat
Est: $0.04
Act: $0.06
+44.9%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

Forward P/E
PEG Ratio
Price/Book
Avg Volume
52W High
52W Low
52W Range Position

ETF Contagion Visualizer

Simulate a price drop in Alphatec Holdings, Inc. to visualize passive redemption contagion across ETFs and collateral stocks.

ATEC Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
ATECEpicenterVHTETFXHEETFLLYLow RiskJNJLow RiskABBVMed RiskUNHMed RiskMRKLow Risk
ATEC Price Drop (%)0

If Alphatec Holdings, Inc. (ATEC) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Eli Lilly & Co. (LLY) as the most exposed collateral stock, sharing 1 ETFs with ATEC. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 2 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

ATEC Ownership Dynamics

Ticker
ATEC

ETFs with Highest ATEC Exposure

Float lock-up computed from 3 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-08138,239$7.75$1.1M
2026-05-0757,754$6.99$403,700.46
2026-05-05129,545$10.33$1.3M
2026-05-04136,505$10.43$1.4M
2026-05-01163,571$9.76$1.6M
2026-04-30163,529$9.30$1.5M
2026-04-071,190$10.97$13,054.3
2026-04-0264,990$11.26$731,787.4
2026-04-0168,753$10.88$748,032.64
2026-03-25658$11.75$7,731.5
2026-03-235,701$12.37$70,521.37
2026-03-1898,521$13.05$1.3M
2026-03-1741,913$12.60$528,103.8
2026-03-10184,608$12.87$2.4M
2026-03-062,136$12.57$26,849.52
2026-02-2493,786$13.16$1.2M
2026-02-122,191$13.47$29,512.77
2026-01-27441$15.68$6,914.88
2026-01-262,422$15.62$37,831.64
2026-01-232,768$15.80$43,734.4
2026-01-221$17.03$17.03
2026-01-05758$20.76$15,736.08
2025-12-226,897$20.01$138,008.97
2025-12-192,869$19.87$57,007.03
2025-12-181,694$19.57$33,151.58
2025-12-124,407$19.91$87,743.37
2025-12-1057$20.67$1,178.19
2025-12-09221,166$20.96$4.6M
2025-11-20750$19.62$14,715
2025-11-17694$19.74$13,699.56

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare ATEC to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.